Patent directory · USPTO A61K / A61P
Patents matching “Theravance Biopharma R&D IP, LLC”
252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9012460
1-(2-phenoxymethylphenyl)piperazine compounds
granted -
US 9012485
Dual-acting imidazole antihypertensive agents
granted -
US 9000191
Serotonin reuptake inhibitors
granted -
US 8993752
Neprilysin inhibitors
granted -
US 8969367
Crystalline forms of a 3-carboxypropyl-aminotetralin compound
granted -
US 8969370
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
granted -
US 8969403
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
granted -
US 8962653
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
granted -
US 8952031
Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
granted -
US 8946233
Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
granted -
US 8933111
Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester
granted -
US 8933249
3-(phenoxyphenylmethyl)pyrrolidine compounds
granted -
US 8927573
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted -
US 8921372
Inhibitors of hepatitis C virus
granted -
US 8921395
Crystalline forms of a biphenyl compound
granted -
US 8921396
Crystalline freebase forms of a biphenyl compound
granted -
US 8912334
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 8901169
Neprilysin inhibitors
granted -
US 8895755
Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
granted -
US 8889882
Process for preparing biphenyl imidazole compounds
granted -
US 8883135
Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
granted -
US 8871792
Neprilysin inhibitors
granted -
US 8865755
Dual-acting antihypertensive agents
granted -
US 8853427
Neprilysin inhibitors
granted